BIOBURDEN-BASED WOUND MANAGEMENT: A NEW PARADIGM. Ryan H. Fitzgerald, DPM, FACFAS

Similar documents
Biofilm and Advanced Wound Management Strategies

Biofilms and Chronic Wounds: Winning the War in Wounds. Prof. Gregory Schultz, Ph.D.

Understanding and Managing

RN Cathy Hammond. Specialist Wound Management Service at Nurse Maude Christchurch

Regenerative Tissue Matrix in Treatment of Wounds

Embrace the Call to Wound Prevention and Care

Dressings do not heal wounds properly selected dressings enhance the body s ability to heal the wound. Progression Towards Healing

Mean percent reduction in ulcer area from baseline at six weeks 62 % SANTYL Ointment + supportive care* + sharp debridement 1 (P<0.

A New Approach To Diabetic Foot Ulcers Using Keratin Gel Technology

INTRODUCTION TO WOUND DRESSINGS

Bactisure Wound Lavage. Advancing Biofilm Removal

Essity Internal. Taking the fear out of wound infection: conquering everyday issues

Wound Management. E. Foy White-Chu, MD, CWSP

The Georgetown Team Approach to Diabetic Limb Salvage: 2013

CLINICAL EVIDENCE Negative Pressure Wound Therapy (NPWT)

What did we find living under some silver dressings? * NEW in vitro Evidence. Not all silver dressings are created equal. *As demonstrated in vitro

Lower Extremity Wound Evaluation and Treatment

The Risk. Background / Bias. Integrating Wound Care into a Limb Preservation Initiative 4/24/2009

CLINICAL EVIDENCE Partial and Deep Partial Burns

CASE 1: TYPE-II DIABETIC FOOT ULCER

easy made Biofilm-based wound care with cadexomer iodine

Workshop on Debridement

Galen ( A.D) Advanced Wound Dressing

Wound Healing: General Principles. Mansour Dib MD

Comprehensive Care and Management of Foot Infection in an Immunocompromised Patient: A Case Report

SDMA Categorisation of Wound Care and Associated Products

Biofilms are free floating

TIME CONCEPT AND LOCAL WOUND MANAGEMENT

INTEGRATED THERAPEUTIC SOLUTIONS TO MANAGE AND PREVENT DIABETIC FOOT ULCERS

We look forward to serving you.

Fish Skin Grafts Promote Superior Cell Ingrowth Compared to Amnion Allografts, Human Cadaver Skin and Mammalian Extracellular Matrix (ECM)

Categorisation of Wound Care and Associated Products

Agenda (45 minutes) Some questions for you. Which wound dressing? Dressing categories/types. Summary

Hemostasis Inflammatory Phase Proliferative/rebuilding Phase Maturation Phase

Diabetic Foot Ulcer Treatment and Prevention

Chronic wounds need an ideal microenvironment. NEXODYN TM can support the physiological healing process.

The right dressing does make a difference

Appropriate Dressing Selection For Treating Wounds

EWMA Educational Development Programme. Curriculum Development Project. Education Module. Wound Infection

Genadyne A4 and foam to treat a postoperative debridment flank abscess

This article is based on a symposium held

Wound Care in the Community. Lisa Sutherland MSc Tissue Viability Senior Lead Ipswich Hospital & Community NHS Trusts

Interleukin-20 is associated with delayed healing in diabetic wounds

Prontosan. Clean. Easy Wound Healing. Wound Cleansing

Expert Recommendations for Optimizing Outcomes in the Management of Biofilm to Promote Healing of Chronic Wounds

Prontosan. Clinical and Scientific Evidence

Topical nanocrystalline silver cream inhibits expression of matrix metalloproteinase-9 in animal models of allergic contact dermatitis.

A comprehensive study on effect of collagen dressing in diabetic foot ulcer

Diagnosing wound infection - a clinical challenge

Disclosures for Tarik Alam. Wound Bed Preparation. Wound Prognosis. Session Objectives. Debridement 4/26/2015

WOUND CARE UPDATE. -Commonly Used Skin Substitute Products For Wound. -Total Contact Casting. Jack W. Hutter DPM, FACFAS, C. ped.

VACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur

How Wounds Heal: A Guide for the Wound-care Novice

Eric J. Lullove, DPM, CWS, FACCWS. Wounds 2017;29(4):

Partnering the burn community

CLINICAL EVIDENCE Treatment of Diabetic Foot Ulcers (DFUs)

comfortable healing customizable infection control antimicrobial exudate control evidence conformable biofilm control absorbency tested advanced

Topical antimicrobials (antiseptics) Iodine, Silver, Honey

ULCERS 1/12/ million diabetics in the US (2012) Reamputation Rate 26.7% at 1 year 48.3% at 3 years 60.7% at 5 years

Consider the possibility of pressure ulcer development

Surgical Wounds & Incisions

with Instillation (i-npwt) in the management of the severely infected ulceration of the diabetic foot (DF).

Topical antimicrobial agents in wound care. Professor Val Edwards-Jones Manchester Metropolitan University UK

made PRODUCTS FOR PRACTICE

Management of Complex Wounds with Vacuum Assisted Closure

Wound Jeopardy: Name That Wound Session 142 Saturday, September 10 th 2011

Vacuumed Assisted Closure

Bioburden-Biofilms in Inflammation

Surgical site infections have been

Enluxtra Self-Adaptive Wound Dressing

Tissue repair. (3&4 of 4)

Current Status of Pressure Ulcer Management in the US Geriatric Population Gregory A Bohn, MD MAPWCA, ABPM/UHMS

Case 1. July 14, th week wound gel 3 cm x 2.5 cm = 7.5 cm². May 25, st wound gel on 290 days PI treatment 4 cm x 2.4 cm = 9.

Wound Classification. Overview

Wound and Ostomy Care: Basics and Troubleshooting

Arglaes provides a seven-day, non-cytotoxic barrier against infection

V.A.C. VeraFlo Therapy can help.

Scott E. Palmer, V.M.D. Diplomate, A.B.V.P., Eq. Practice New Jersey Equine Clinic

Your guide to wound debridement and assessment. Michelle Greenwood. Lorraine Grothier. Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust

Foam dressings have frequently

DRESSING SELECTION. Rebecca Aburn MN NP Candidate

2008 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. CPT Copyright 2007 American Medical Association

DISCLOSURE STATEMENT 10/8/ BASIC OF ELEMENTS OF LIMB SALVAGE MANAGEMENT

DRESSING SELECTION SIMPLIFIED

Acute and Chronic WOUND ASSESSMENT. Wound Assessment OBJECTIVES ITEMS TO CONSIDER

Identification and management of biofilm in chronic wounds

Wound Bed Preparation and Infected Wounds in Patients With Diabetes

Prepares wounds to allow natural healing

Nanogen Aktiv. Naz Wahab MD, FAAFP, FAPWCA Nexderma

Conference Report: The Wound Infection Summit. Kings College Hospital, London; March 2013

Debridement within the context of the EWMA s debridement guidelines. Emil Schmidt WCNS SDHB - Otago

Making the Most of your Dressing Products Catherine Hammond CNS/CNE

Discussion Topics. Calcium Alginates. DME For the Diabetic Foot 1/25/2017. Jeffrey D. Lehrman, DPM, FASPS, FACFAS, MAPWCA

Management Of The Diabetic foot

11/8/2018. A Clean Wound Bed is a Healing Wound Bed. Wound Cleansing

Orthopaedica Belgica 2018

MolecuLight i:x Wound Intelligence Device

Advancing the science of wound bed preparation

Transmetatarsal amputation in an at-risk diabetic population: a retrospective study

Cytoflex Barrier Membrane Clinical Evaluation

Transcription:

BIOBURDEN-BASED WOUND MANAGEMENT: A NEW PARADIGM Ryan H. Fitzgerald, DPM, FACFAS

Contamination Presence of non-replicating microorganisms on the wound surface that evoke no clinical host response - All chronic wounds are contaminated - Bacterial colony counts low - Planktonic - Wound healing occurs in spite of bacteria presence 1. AWMA. Bacterial impact on wound healing: From contamination to infection. 2011.

Colonization Bacteria that have adhered to superficial tissue (sessile) Have begun to form colonies without generating a host immune response Not typically associated with a delay in healing 1. Thomas. Understanding Wound Infection and the Role of Biofilms. AAWC, 2008.

Critical Colonization The inability of the wound to maintain a balance between altered bioburden and an effective immune system Results in unexplained delay in healing -prolongation of the inflammatory phase No overt signs of clinical infection or wound deterioration 1. Cutting. Understanding Wound Infection and the Role of Biofilms. AAWC. 2008

Biofilm Densely packed communities of microbial cells that grow on surfaces and surround themselves with Extracellular Polymeric Substance (EPS) Biofilms develop defenses from topical agents, and impair wound healing - Inflammatory immune response - Impairs granulation tissue formation - Impairs epithelialization 1. Metcalf D, Bowler P. Biofilm Delays Wound Healing: Reviewing the Evidence. ConvaTec Inc. 2013

How quickly do biofilms form? Strongly attached micro-colonies - 2-4 hours Develop initial EPS - 6-12 hours Evolve into fully mature biofilm colonies - 2-4 days Rapidly recover from mechanical disruption (debridement) - Within 24 hours 1. Phillips. Biofilms Made Easy. 2010

Biofilm Prevalence and Impact >90% of chronic wounds possess biofilm Biofilm may delay and impair the healing process - Each year, as many as 17 million new biofilm infections occur in the US - 65%-80% of all human infectious disease is caused by biofilm 1. Wolcott. The role of biofilms: are we hitting the right target? 2011 2. Wolcott. Understanding Wound Infection and the Role of Biofilms. AAWC. 2008

Principles of Biofilm Based Wound Care 1. Frequent debridement of wounds to physically remove biofilm communities 2. Use an effective microbicidal dressing after debridement to prevent reformation of biofilms 3. Alter topical & systemic antimicrobial treatments to prevent emergence of dominant bacteria from polymicrobial populations; utilize DNA bacterial identification techniques 4. Biofilm Based Wound Care is part of Wound Bed Preparation (TIME) Wolcott,R.D.; Rhoads,D.D. A study of biofilm-based wound management in subjects with critical limb ischaemia. J.Wound.Care 17:145-154, 2008

TIME Wound bed Assessment

Treatment Strategy

Treatment strategy 1 1. Phillips. Biofilms Made Easy. 2010

Treatment challenges Systemic antibiotics Fail to reach adequate local tissue levels - Topical antiseptics in conjunction with systemic therapy may be more effective Debridement Frequent debridement allows for treating agents to be most effective Effective in the clinic setting? - Biofilm rapidly reconstitutes itself on the surface within 24 hours Topical Antimicrobials Tissue compatibility? Broad spectrum? Resistance? 1. Wolcott. Understanding Wound Infection and the Role of Biofilms. AAWC. 2008

Facing this New Problem do we need a A New Paradigm? We need to be able to suppress Biofilm formation in chronic wounds Barrier Dressings? NPWT Instillation? Synthetic Graft products with antimicrobial properties?

Barrier Dressings Passive Antimicrobial Defense Protecting the wound or the dressing? Tissue Compatibility? Efficacy

Can Dressings Disrupt & Kill Mature Biofilms? PL Phillips, Q Yang, E Sampson, GS Schultz. Effects of antimicrobial agents on an in vitro biofilm model of skin wounds. Adv Wound Care 2010; 1: 299-304.

24 hr Continuous Exposure of Mature PAO1 Biofilm on Porcine Explants P.L. Phillips, Q. Yang, E. Sampson, G. Schultz. Effects of Antimicrobial Agents on an In Vitro Biofilm Model of Skin Wounds, Advances Wound Care, 1: 299-304, 2010.

NPWT Utilization of existing NPWT modality with instillation Wound Lavage Wound Chemotherapy Saline PVP PHMB

Assessment of NPWT+ Instillation on Biofilms Grown on Pig Skin Explants Instill NP port Fix center 8mm biopsies cut from under both NP and instill ports for SEM analysis; Trump fixative NP NP port Check for leaks, NP NP pressure, Instillation, Saturation of wound and foam before NPWT and final collection canister volume to verify completion of 6 cycles. P.L. Phillips, Q. Yang, G.S. Schultz. Effect of Negative Pressure Wound Therapy with Periodic Instillation Using Antimicrobial Solutions on Pseudomonas aeruginosa Biofilm on Porcine Skin Explants. International Wound J, 10 (suppl. 1) 48-55, 2013.

Log CFU/ml Effects of 6-Cycles of NPWT-Instill Treatments Over 24 Hours on P. aeruginosa Biofilm Grown on Pig Skin Explants 9 8 VAC Port *** Instillation Port 7 6 5 4 * * * * 3 2 1 0 Phillips P, Yang Q, Schultz G. unpublished * P-Value <0.005 compared to saline control

Advanced Tissue Products Dermal regenerative scaffolds Collagen Matrix Antimicrobial Elements Silver Copper PHMB

Importance of Collagen Collagen is the main structural protein in the extracellular space of connective tissue ECM controls many cellular functions, including cell shape and differentiation, migration and protein synthesis 28 types of collagen identified so far Type 1 collagen most common (80%-90%) and found in all tissues the primary collagen in a healed wound Sabiston textbook of surgery board review, 7th edition. Chapter 5

Importance of Retaining Native Structure ECMs that retain native tissue structure were found to inhibit a wider range of MMPs, including collagenases, gelatinase and neutrophil elastase Oxidized regenerated cellulose/collagen shown only to inhibit gelatinases Conclusion Native biomaterials that are capable of inhibiting both upstream (i.e. collagenases) and downstream (i.e. gelatinases) proteases are more likely to halt collagen proteolysis Negron L, Lun S, May BCH. Ovine forestomach matrix biomaterial is a broad spectrum inhibitor of matrix metalloproteinases and neutrophil elastase. Int Wound J 2012

Purified Collagen Matrix with PHMB The first and only purified collagen matrix plus PHMB antimicrobial Purified Type 1 collagen matrix coated with broad-spectrum antimicrobial PHMB 1a Acute and chronic wound management across a variety of wound types 1 a PHMB = polyhexamethylenebiguanide hydrochloride 1. PuraPly antimicrobial [package insert]. Canton, MA: Organogenesis, Inc; 2015.

PHMB: mechanism of action Interacts with negatively charged phospholipids in the bacterial membrane (leading to disruption) Inhibits bacterial cell metabolism Shown to effectively remove biofilm through blocking microbial attachments to surfaces Binds to cellular surfaces for sustained effect over hours 1. Hübner NO, Kramer A. Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacol Physiol. 2010;23(suppl):17-27.

In vitro scientific data 1 PHMB Antimicrobial effectively inhibited microorganisms 1 1. Data on file. Organogenesis, Inc. a United States Pharmacopeia Antimicrobial Effectiveness Test showed reduced concentrations at days 7, 14, and 28 B Zone of inhibition test demonstrated efficacy in vitro

Preclinical partial thickness wound model Natural Collagen with PHMB Antimicrobial demonstrated greater reduction in MRSA vs other products 1 1. Data on file. Organogenesis, Inc.

Bioburden Based Wound Management!

CASE PRESENTATIONS

67-year-oldAfricanAmerican male presented with a pressure ulcer on the left heel at the site of a previously closed wound likely due to shearing in a Crow Boot while walking on prosthesis on the right. Wound present for 2 months and was previously treated with negative pressure wound therapy (NPWT) PMH: includes diabetes, peripheral vascular disease, hypertension, neuropathy, gout, ESRD, hyperlipidemia, anemia, osteomyelitis (right heel) Surgical history includes partial calcanectomy bilaterally (May 6, 2014), right BKA (May 9, 2014),and surgical resection of left heel (May 13, 2014)

Pressure Ulcer (heel) closed after 9 applications Before After

PuraPly Antimicrobial Initiated Week 1 Wound with significant slough, devitalized tissue and edema. Pre-debridement Date: 6/29/15 Wound Size: 4.0 x 4.5 x Wound Area: 18.0 cm 2 0.2 cm Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: Total contact cast (TCC)

2 nd Application Week 2 Reduction in wound size with increased granulation tissue. Pre-debridement Date: 7/6/15 Wound Size: 3.7 x 4.2 x 0.2 cm Wound Area: 15.54 cm 2 Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

3 rd Application Week 3 Continued reduction in wound size despite complete wound dressing change during the prior week. Pre-debridement Date: 7/13/15 Wound Size: 2.4 x 4.0 x 0.2 cm Wound Area: 9.6 cm 2 Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

4 th Application Week 4 Continued reduction in wound size. Pre-debridement Date: 7/20/15 Wound Size: 2.3 x 4.0 x 0.2 cm Wound Area: 9.3 cm 2 Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

5 th Application Week 5 Continued reduction in wound size with some peri-wound maceration; additional nursing visits added to manage drainage. Pre-debridement Date: 7/27/15 Wound Size: 2.1 x 3.3 x 0.1 cm Wound Area: 6.93 cm 2 Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

6 th Application Week 6 Continued reduction in wound size and maceration improved. Pre-debridement Date: 8/3/15 Wound Size: 1.4 x 3.0 x 0.1 cm Wound Area: 4.2 cm 2 Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

7 th Application Week 7 Continued reduction in wound size. Pre-debridement Date: 8/10/15 Wound Size: 1.2 x 2.5 x 0.1 cm Wound Area: 3.0 cm 2 Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

8 th Application Week 8 Continued reduction in wound size with no signs of peri-wound maceration. Pre-debridement Date: 8/17/15 Wound Size: 0.7 x 2.1 x 0.1 Wound Area: 1.47 cm 2 cm Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

9 th Application Week 9 Continued reduction in wound size. Pre-debridement Date: 8/24/15 Wound Size: 0.2 x 0.7 x 0.1 cm Wound Area: 0.14 cm 2 Wound Bed Prep: Sharp debridement Primary Dressings: Restore Secondary Dressings: Calcium alginate, Kling, Ace Off-loading: TCC

Wound Closed Week 10 Patient received 9 Applications of PuraPly Antimicrobial. Complete Wound Closure Date: 8/31/15 Wound Size: closed Wound Healed: Offloading continued Off-loading: TCC

59 y/o female with a history of a puncture wound and subsequent ulceration sub 5 th metatarsal wound which extends dorsally to a dorsal wound PMH: PAD, Peripheral neuropathy SH 12/14/15 Plantar Dorsal Prior to first application

SH 12/28/15 Plantar Dorsal After 1 st application

SH 01/04/16 Plantar Dorsal After 2 nd Application

SH 01/11/16 After 3 rd Application

SUMMARY All wounds have some level of bioburden 1 90% of chronic wounds have biofilm 2 Excessive bioburden can adversely affect tissue repair and delay healing 1,3 Excess protease activity in chronic wounds degrade the collagen matrix thereby inhibiting healing 4 1 Mulder GD, Cavorsi JP, Lee DK. Wounds. 2007;19(7):173-182. 2 Wolcott R, Cutting KF, Ruiz JC. Association for the Advancement of Wound Care; 2008:12-17. 3 Hubner NO, Kramer A. Skin Pharmacol Physiol. 2010;23(suppl):17-27. 4 Li Z, et al., Journal of Diabetes and Its Complications. 2013. 5 Negron L, Lun S, May BCH. Int Wound J. 2012. 6 Data on file. Organogenesis, Inc.

SUMMARY A new paradigm that adds the management of biofilm and suppression of bioburden to pre-existing standard modalities Staged wound healing Appropriate offloading Wound bed preparation Progression to closure